Access cutting-edge b-cell lymphoma treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access b-cell lymphoma specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-cell lymphoma treatment provided free
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab with or without Acalabrutinib in Subjects with Indolent B-Cell Non-Hodgkin Lymphoma That has Relapsed or is Refractory to Rituximab
Sponsor: BioInvent International AB
Check if you qualify for this b-cell lymphoma clinical trial in Atlanta, GA
If you're searching for b-cell lymphoma treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.